Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase II study of ABP1019 in advanced solid tumors
CTR20250008Phase 2Active
- Sponsor
- EyeBio
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABP 1019 in Nonhematologic neoplasms, sponsored by EyeBio. Started Jan 2025; status: active.
02
Drugs
ABP 1019
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20250008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250008.